Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD HEALTH
06618
5
BIDU-SW
09888
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 179.26%1.72B | ---- | 375.46%615.38M | ---- | 103.16%129.43M | ---- | -25,642.48%-4.1B | ---- | -86.30%16.06M |
| Profit adjustment | ||||||||||
| Investment loss (gain) | ---- | 76.26%-62.22M | ---- | -568.96%-262.1M | ---- | 12.72%-39.18M | ---- | 41.42%-44.89M | ---- | -181.68%-76.63M |
| Impairment and provisions: | ---- | 21.99%-396.56M | ---- | -285.80%-508.34M | ---- | -69.64%273.59M | ---- | 534.62%901.13M | ---- | -72.72%141.99M |
| -Other impairments and provisions | ---- | 9.00%-502M | ---- | -266.37%-551.64M | ---- | -30.70%331.57M | ---- | 569.64%478.42M | ---- | -68.25%71.45M |
| Revaluation surplus: | ---- | -217.48%-10M | ---- | -298.88%-3.15M | ---- | ---789.66K | ---- | ---- | ---- | ---217.41K |
| Asset sale loss (gain): | ---- | 13.02%-2.53M | ---- | -4.41%-2.91M | ---- | -119.54%-2.79M | ---- | 346.18%14.26M | ---- | -159.47%-5.79M |
| -Loss (gain) on sale of property, machinery and equipment | ---- | 13.02%-2.53M | ---- | -4.41%-2.91M | ---- | -119.54%-2.79M | ---- | 346.18%14.26M | ---- | -159.47%-5.79M |
| Depreciation and amortization: | ---- | 4.62%745.87M | ---- | -6.06%712.91M | ---- | 22.88%758.9M | ---- | -19.68%617.61M | ---- | -14.39%768.97M |
| -Amortization of intangible assets | ---- | 30.30%111.95M | ---- | -7.84%85.92M | ---- | -1.44%93.23M | ---- | 5.42%94.59M | ---- | -4.16%89.72M |
| -Other depreciation and amortization | ---- | 248.71%5.85M | ---- | -61.51%1.68M | ---- | 29.83%4.36M | ---- | -58.52%3.36M | ---- | -44.84%8.1M |
| Financial expense | ---- | -21.25%152.62M | ---- | -20.37%193.8M | ---- | 12.12%243.37M | ---- | 13.64%217.05M | ---- | 56.55%191M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -129.35%-3.61B | ---- | -2,238.19%-1.57B | ---- | 93.48%-67.23M | ---- | -198.99%-1.03B | ---- | -37.04%1.04B |
| Accounts receivable (increase)decrease | ---- | 405.43%2.38B | ---- | 26.11%-779.05M | ---- | 76.93%-1.05B | ---- | -161.77%-4.57B | ---- | -15.41%-1.75B |
| Accounts payable increase (decrease) | ---- | -70.35%954.12M | ---- | -0.03%3.22B | ---- | -56.43%3.22B | ---- | 336.62%7.39B | ---- | 133.04%1.69B |
| Special items of business | ---- | -415.27%-2.12B | ---- | -47.83%671.51M | ---- | -21.68%1.29B | ---- | 4,001.52%1.64B | ---- | 5.07%-42.12M |
| Adjustment items of business operations | 323.20%3.19B | 16.27%1.88B | -208.17%-1.43B | -53.39%1.61B | 60.19%1.32B | 667.27%3.46B | 164.66%825.36M | -130.15%-609.92M | 36.73%-1.28B | 160.38%2.02B |
| Net cash from operations | 323.20%3.19B | -110.59%-241.97M | -208.17%-1.43B | -51.88%2.28B | 60.19%1.32B | 359.30%4.75B | 164.66%825.36M | -47.82%1.03B | 36.73%-1.28B | 158.35%1.98B |
| Cash flow from investment activities | ||||||||||
| Dividend received - investment | 20.39%9.41M | -12.86%24.85M | 232.54%7.81M | -70.05%28.51M | 702.76%2.35M | 0.85%95.22M | -99.00%292.65K | -42.47%94.42M | 149.22%29.19M | 150.54%164.12M |
| Sale of fixed assets | -11.96%5.08M | 28.07%11.52M | 94.13%5.77M | 0.67%9M | 227,207.25%2.97M | -89.27%8.94M | -99.99%1.31K | 906.03%83.27M | 767.21%13.27M | 172.14%8.28M |
| Purchase of fixed assets | -7.44%-625.43M | -54.44%-1.68B | -36.75%-582.09M | -192.40%-1.09B | -110.37%-425.65M | 0.80%-372.92M | -49.16%-202.33M | -7.25%-375.95M | -46.60%-135.65M | 28.77%-350.53M |
| Sale of subsidiaries | ---- | -8,740.63%-1.76M | ---- | --20.37K | ---- | ---- | ---- | ---- | --2.74M | ---- |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---95.26M | ---87.67M | ---- | ---- | 100.00%379.62 | ---- | 42.59%-277.61M |
| Recovery of cash from investments | 41.67%1.7B | -27.79%1.26B | 104.89%1.2B | 154.51%1.75B | --585.67M | -86.70%687.86M | ---- | 101.93%5.17B | 416.45%3B | 359.65%2.56B |
| Cash on investment | -233.81%-2.12B | 67.93%-664.62M | -58.53%-634.76M | -89.19%-2.07B | -326.78%-400.41M | 72.81%-1.1B | 94.81%-93.82M | -31.55%-4.03B | -106.98%-1.81B | -16.72%-3.06B |
| Other items in the investment business | -2,350.78%-21.33M | 90.75%-22.05M | -75.41%947.54K | -1,587.69%-238.36M | -52.81%3.85M | -45.19%16.02M | -1.04%8.17M | 113.13%29.23M | 19,707.77%8.25M | -87.91%-222.65M |
| Net cash from investment operations | -45,082.43%-1.05B | 37.26%-1.07B | 99.27%-2.33M | -158.70%-1.71B | -10.84%-318.89M | -167.75%-660.43M | -125.92%-287.7M | 182.62%974.76M | 395.22%1.11B | 61.85%-1.18B |
| Net cash before financing | 249.46%2.14B | -328.25%-1.31B | -242.78%-1.43B | -85.91%575.66M | 86.60%1B | 103.49%4.09B | 423.10%537.66M | 150.71%2.01B | 93.05%-166.41M | 112.35%801.06M |
| Cash flow from financing activities | ||||||||||
| New borrowing | 16.51%618.13M | -47.57%1.13B | -53.07%530.52M | -48.23%2.16B | -51.66%1.13B | -12.28%4.18B | 105.21%2.34B | -14.34%4.76B | -12.68%1.14B | -33.18%5.56B |
| Refund | 23.11%-942.83M | 49.49%-1.86B | -15.96%-1.23B | 22.36%-3.68B | 28.08%-1.06B | 7.39%-4.75B | -19.76%-1.47B | -7.78%-5.12B | -6.33%-1.23B | -13.42%-4.75B |
| Dividends paid - financing | 15.05%-70.71M | -21.83%-276.34M | 29.41%-83.23M | 19.57%-226.83M | 44.21%-117.92M | 13.23%-282.03M | -74.66%-211.36M | -9.18%-325.04M | 8.56%-121.01M | -76.40%-297.7M |
| Absorb investment income | ---- | ---- | ---- | 34,973.08%1.71B | 200.00%14.67M | -86.56%4.89M | -75.42%4.89M | -95.81%36.37M | -41.50%19.89M | --866.98M |
| Other items of the financing business | -103.44%-3.54M | -63.94%200.86M | 1,290.65%102.85M | 45.20%557.1M | -4.70%-8.64M | 8,696.36%383.67M | -16.54%-8.25M | -20.31%-4.46M | -258.88%-7.08M | -463.21%-3.71M |
| Net cash from financing operations | 40.99%-398.95M | -253.95%-803.43M | -1,640.11%-676.02M | 212.46%521.88M | -105.94%-38.85M | 29.45%-464.07M | 432.91%653.53M | -148.10%-657.77M | -491.76%-196.31M | -65.44%1.37B |
| Effect of rate | -27.58%-73.25M | -641.25%-73.09M | -569.50%-57.41M | -129.87%-9.86M | 5.62%12.23M | 219.59%33.01M | 290.25%11.58M | 59.18%-27.6M | -57.86%2.97M | -394.83%-67.62M |
| Net Cash | 182.62%1.74B | -292.92%-2.12B | -318.63%-2.11B | -69.70%1.1B | -19.04%964.43M | 168.23%3.62B | 428.41%1.19B | -37.72%1.35B | 84.52%-362.72M | 185.66%2.17B |
| Begining period cash | -12.61%15.17B | 6.68%17.36B | 6.58%17.36B | 28.96%16.28B | 29.09%16.29B | 11.71%12.62B | 11.71%12.62B | 22.84%11.3B | 22.84%11.3B | -21.43%9.2B |
| Cash at the end | 10.82%16.84B | -12.61%15.17B | -11.99%15.2B | 6.68%17.36B | 24.92%17.27B | 28.96%16.28B | 26.38%13.82B | 11.71%12.62B | 59.43%10.94B | 22.84%11.3B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Dahua Certified Public Accountants (Special General Partnership) | -- | Dahua Certified Public Accountants (Special General Partnership) | -- | Dahua Certified Public Accountants (Special General Partnership) | -- | Dahua Certified Public Accountants (Special General Partnership) | -- | Dahua Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.